journal article·2014-05

Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering

Gui-Xin Ruan, Yu-Zhe Chen, Xing-Lei Yao, Anariwa Du, Gu-Ping Tang, You-Qing Shen, Yasuhiko Tabata, Jian-Qing Gao

Acta Biomaterialia· Volume 10· Issue 5
Publisher page

Abstract

Macrophages are the most plastic cells in the hematopoietic system and they exhibit great functional diversity. They have been extensively applied in anti-inflammatory, anti-fibrotic and anti-cancer therapies. However, the application of macrophages is limited by the efficiency of their engineering. The macrophage mannose receptor (MMR, CD206), a C-type lectin receptor, is ubiquitously expressed on macrophages and has a high affinity for mannose oligosaccharides. In the present study, we developed a novel non-viral vehicle with specific affinity for MMR. Mannan was cationized with spermine at a grafted ratio of ∼12% to deliver DNA and was characterized as a stable system for delivery. This spermine-mannan (SM)-based delivery system was evaluated as a biocompatible vehicle with superior transfection efficiency on murine macrophages, up to 28.5-fold higher than spermine-pullulan, 11.5-fold higher than polyethylenimine and 3.0-fold higher than Lipofectamine™ 2000. We confirmed that the SM-based delivery system for macrophages transfection was MMR-specific and we described the intracellular transport of the delivery system. To our knowledge, this is the first study using SM to demonstrate a mannose receptor-specific gene delivery system, thereby highlighting the potential of a novel specific non-viral delivery vehicle for macrophage engineering.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Phagocytosis and Immune Regulation · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Macrophage biology in development, homeostasis and disease10.1038/nature12034 ↗
2. Macrophage regulation of tumor responses to anticancer therapies10.1016/j.ccr.2013.02.013 ↗
3. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets10.1189/jlb.72.3.417 ↗
4. In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery10.1038/sj.gt.3301290 ↗
5. Eukaryotic expression plasmid transfer from the intracellular bacterium Listeria monocytogenes to host cells10.1046/j.1462-5822.2001.00138.x ↗
6. Transfection of human immunodeficiency virus type 1 proviral DNA into primary human monocytes10.1006/cimm.1993.1098 ↗
7. Transfection of myelomonocytic cell lines: cellular response to a lipid-based reagent and electroporation10.1006/abio.1999.4024 ↗
8. Therapeutic gene modified cell based cancer vaccines10.1016/j.gene.2013.03.056 ↗
9. The expression of exogenous genes in macrophages: obstacles and opportunities10.1007/978-1-59745-396-7_9 ↗
10. Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA10.4049/jimmunol.168.1.411 ↗
11. Receptor-mediated gene transfer into macrophages10.1073/pnas.93.1.101 ↗
12. Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides10.1002/jlb.65.2.270 ↗
13. Ligand recognition by antigen-presenting cell C-type lectin receptors10.1016/j.coi.2004.12.001 ↗
14. C-type lectin receptors on dendritic cells and Langerhans cells10.1038/nri723 ↗
15. The mannose receptor10.1189/jlb.0512231 ↗
16. Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor10.1074/jbc.M002366200 ↗
17. A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups10.1016/j.biomaterials.2012.05.006 ↗
18. Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure10.1089/hum.2009.106 ↗
19. Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting10.1016/j.ijpharm.2009.03.033 ↗
20. PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes10.1016/j.biomaterials.2012.07.022 ↗
21. Recent developments in carbohydrate-decorated targeted drug/gene delivery10.1002/med.20171 ↗
22. Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery10.1016/j.biomaterials.2011.06.025 ↗
23. Identification of two Saccharomyces cerevisiae cell wall mannan chemotypes10.1128/JB.111.3.690-695.1972 ↗
24. Effect of amine type on the expression of plasmid DNA by cationized dextran10.1163/156856209X415549 ↗
25. Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity10.1016/j.ijpharm.2009.12.033 ↗
26. Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection10.1016/j.nano.2013.06.003 ↗
27. N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex10.1248/bpb.32.706 ↗
28. Mannosylated biodegradable polyethyleneimine for targeted DNA delivery to dendritic cells10.2147/IJN.S31760 ↗
29. Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA10.1038/sj.gt.3301735 ↗
30. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls10.1038/mt.2009.281 ↗
31. Tethering functional ligands onto shell of ultrasound active polymeric microbubbles10.1021/bm050723g ↗
32. Polyethylenimine-based non-viral gene delivery systems10.1016/j.ejpb.2004.11.011 ↗
33. Membrane and nuclear permeabilization by polymeric pDNA vehicles: efficient method for gene delivery or mechanism of cytotoxicity?10.1021/mp200368p ↗
34. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner10.1158/1078-0432.CCR-11-1354 ↗
35. CD205 (DEC-205): a recognition receptor for apoptotic and necrotic self10.1016/j.molimm.2008.11.016 ↗
36. Kruppel-like factor 4 regulates macrophage polarization10.1172/JCI45444 ↗
37. Variable antigen uptake due to different expression of the macrophage mannose receptor by dendritic cells in various inbred mouse strains10.1111/j.1365-2567.2008.02960.x ↗
38. Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation10.1111/j.1365-2567.2006.02512.x ↗
39. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses10.1016/S0092-8674(00)80693-5 ↗
40. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR10.1126/science.1066371 ↗
41. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation10.1016/j.molimm.2009.09.026 ↗
42. Co-transfection gene delivery of dendritic cells induced effective lymph node targeting and anti-tumor vaccination10.1007/s11095-013-0985-8 ↗
43. A novel cationic liposome formulation for efficient gene delivery via a pulmonary route10.1088/0957-4484/22/24/245104 ↗
44. Understanding biophysicochemical interactions at the nano-bio interface10.1038/nmat2442 ↗
45. Regulated portals of entry into the cell10.1038/nature01451 ↗
46. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials10.1002/smll.201100001 ↗
47. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling10.1083/jcb.200908086 ↗
48. Cellular uptake of cationic polymer–DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells10.1007/s11095-007-9287-3 ↗
49. Cell cycle dependent transcription, a determinant factor of heterogeneity in cationic lipid-mediated transgene expression10.1002/jgm.1010 ↗
50. Barriers to non-viral vector-mediated gene delivery in the nervous system10.1007/s11095-010-0364-7 ↗